XML 15 R4.htm IDEA: XBRL DOCUMENT v3.25.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Expenses:    
Research and development $ 466,745 $ 98,667
General and administrative 1,071,258 472,028
Total operating expenses 1,538,003 570,695
Loss from operations (1,538,003) (570,695)
Other Income (Expenses):    
Interest income 10,365 62
Loss on change in fair value of derivative liability (37,711)
Interest expense (1,229) (65,756)
Other income 40,000
Total other income (expenses), net 9,136 (63,405)
Net loss $ (1,528,867) $ (634,100)
Net loss per common share:    
Basic $ (0.05) $ (0.02)
Diluted $ (0.05) $ (0.02)
Weighted average number of common stock outstanding:    
Basic 33,103,860 26,526,405
Diluted 33,103,860 26,526,405